Vaccine (mRNA vaccine) · Immune activation · developed by Sanofi Pasteur, a Sanofi Company
Acne mRNA is an mRNA vaccine, a vaccine platform that delivers messenger RNA to induce an immune response. It is studied in acne vulgaris.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07756957 | Phase 1/2 | Acne | Recruiting | SNY |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne
See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SNY catalysts and pipeline →